129773928512031250_121Hexun homepage established mobile phone version of the stock/fund market for micro-blogging news blog live small company stocks the major new share placements by gem new third sector brokers New York themesBulletin deal prompted financial calendar results
tera gold, lift ban on memo Finance Treasury capital flows the assessment centre is definitely big deals thousand unit new share purchase financing microblogging unit Moss Forum daily limit pioneer financial management training hexun.com interpretation of stock beer annual report 2011 > body print RSSFont size-March 27, 2012 from: hexun stock Chongqing Brewery (600,132, unit), the 27th annual report, Chongqing brewery operating income $ 2.695 billion for the year 2011, increase of 13.46% compared with the previous year, operating income from all the beerBusiness last year, sales 1.0829 million litres of beer, $ 2.695 billion operating revenue, achieving $ 153.6 million attributable to the shareholders of the parent company's net profit. Chongqing beer last year reported net income of $ 154 million, down 2010. Basic earnings per share of $ 0.32. In addition, Chongqing Brewery has developed a 10 share dividend 2Worth of assignments.
����Changes in the Chongqing beer today, as close up 6.05% per cent to $ 31.04. Hepatitis b vaccines remain uncertain follow-up concern progress in hepatitis b vaccine project
tera gold, Chongqing brewery in content is not disclosed in the annual report, beer says, treatment (synthetic peptides) hepatitis b vaccine alone is set according to the clinical trial protocolIn the Clinical Hospital completed clinical trials. Alone Group clinical research clinical trial reports are currently in preparation stage. According to the preliminary work plan will be completed by April this year clinical study reports. Chongqing brewery said corporate under alone Group clinical trial summary report comments on whether to proceed with the clinical evaluation, follow-up inquiryThere are significant uncertainties.
����Combined group remains in hospital for clinical trials in clinical trials, the project development process is still a greater risk, with significant uncertainties. Beer said, if separate clinical studies of drug use is no longer continuing follow-up clinical studies upon completion of the ongoing clinical studies of the combined group
tera power leveling, the company will be based on jointClinical trial of the drug group's views as to whether to proceed with the evaluation of clinical research, conducting follow-up studies there are significant uncertainties.
Others:
No comments:
Post a Comment